St. Jude Reference #SJ-21-0045

Researchers at St. Jude created small molecules that target protein degradation of GSPT1/IKZF1 for the treatment of cancer (hematological malignancies, solid tumors). These compounds indicate greater potency for degradation over existing small molecules.

Keywords

small molecule, drug, PROTAC. targeted protein degradation, CK1alpha, hematological cancer, solid tumor.

Granted Patents or Published Applications

Application filed, available under confidentiality

Related Scientific References

Licensing Opportunities

We are seeking partners to commercialize these small molecules. 

Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.